AU2001294221A1 - Preventives and remedies for complications of diabetes - Google Patents

Preventives and remedies for complications of diabetes

Info

Publication number
AU2001294221A1
AU2001294221A1 AU2001294221A AU2001294221A AU2001294221A1 AU 2001294221 A1 AU2001294221 A1 AU 2001294221A1 AU 2001294221 A AU2001294221 A AU 2001294221A AU 2001294221 A AU2001294221 A AU 2001294221A AU 2001294221 A1 AU2001294221 A1 AU 2001294221A1
Authority
AU
Australia
Prior art keywords
preventives
remedies
complications
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001294221A
Other versions
AU2001294221B2 (en
Inventor
Masaki Kitahara
Seijiro Mori
Yasushi Saito
Minoru Takemoto
Taro Tamaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Nissan Chemical Corp
Original Assignee
Kowa Co Ltd
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd, Nissan Chemical Corp filed Critical Kowa Co Ltd
Priority claimed from PCT/JP2001/008921 external-priority patent/WO2002030425A1/en
Publication of AU2001294221A1 publication Critical patent/AU2001294221A1/en
Application granted granted Critical
Publication of AU2001294221B2 publication Critical patent/AU2001294221B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001294221A 2000-10-12 2001-10-11 Preventives and remedies for complications of diabetes Ceased AU2001294221B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-311960 2000-10-12
JP2000311960 2000-10-12
PCT/JP2001/008921 WO2002030425A1 (en) 2000-10-12 2001-10-11 Preventives and remedies for complications of diabetes

Publications (2)

Publication Number Publication Date
AU2001294221A1 true AU2001294221A1 (en) 2002-06-27
AU2001294221B2 AU2001294221B2 (en) 2005-09-29

Family

ID=18791637

Family Applications (2)

Application Number Title Priority Date Filing Date
AU9422101A Pending AU9422101A (en) 2000-10-12 2001-10-11 Preventives and remedies for complications of diabetes
AU2001294221A Ceased AU2001294221B2 (en) 2000-10-12 2001-10-11 Preventives and remedies for complications of diabetes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU9422101A Pending AU9422101A (en) 2000-10-12 2001-10-11 Preventives and remedies for complications of diabetes

Country Status (21)

Country Link
US (1) US20040087597A1 (en)
EP (1) EP1325745B1 (en)
JP (1) JPWO2002030425A1 (en)
KR (1) KR100830018B1 (en)
CN (1) CN1230173C (en)
AT (1) ATE401886T1 (en)
AU (2) AU9422101A (en)
CA (1) CA2424060A1 (en)
CZ (1) CZ2003934A3 (en)
DE (1) DE60135000D1 (en)
HK (1) HK1060311A1 (en)
HU (1) HUP0303353A3 (en)
IL (1) IL155173A0 (en)
MX (1) MXPA03003204A (en)
NO (1) NO20031678D0 (en)
NZ (1) NZ525150A (en)
PL (1) PL361097A1 (en)
RU (1) RU2003113328A (en)
SK (1) SK4112003A3 (en)
WO (1) WO2002030425A1 (en)
ZA (1) ZA200302507B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504415B2 (en) 2001-04-19 2009-03-17 Kowa Co., Ltd. Therapeutic agent for glomerular disease
US20060276486A1 (en) * 2003-04-17 2006-12-07 Kowa Co., Ktd. Lklf/klf2 gene expression promoter
JP2005232151A (en) * 2003-04-28 2005-09-02 Iichiro Shimomura Sugar uptake ability-reinforcing agent
EP1618893A4 (en) * 2003-04-28 2009-08-12 Sankyo Co Sugar intake-ability enhancer
US9345671B2 (en) 2003-04-28 2016-05-24 Daiichi Sankyo Company, Limited Adiponectin production enhancer
CN100368374C (en) * 2003-05-23 2008-02-13 兴和株式会社 Carboxylic compound and medicine comprising the same
WO2006064825A1 (en) * 2004-12-14 2006-06-22 Santen Pharmaceutical Co., Ltd. Therapeutic agent for dry eye
EP1785133A1 (en) * 2005-11-10 2007-05-16 Laboratoires Fournier S.A. Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
KR20130137623A (en) * 2010-10-06 2013-12-17 고쿠리츠다이가쿠호우진 도쿄다이가쿠 Prophylactic and/or therapeutic agent lymphedema

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (en) * 1974-06-07 1981-03-18
US4346772A (en) * 1978-01-03 1982-08-31 Clifft Dale L Power assisting device for a manually operating vehicle
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
US4588715A (en) * 1984-06-04 1986-05-13 Sandoz, Inc. Heptenoic acid derivatives
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4804679A (en) * 1984-07-24 1989-02-14 Sandoz Pharm. Corp. Erythro-(E)-7-(3'-C1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
US5001255A (en) * 1984-12-04 1991-03-19 Sandoz Pharm. Corp. Idene analogs of mevalonolactone and derivatives thereof
US4851427A (en) * 1985-10-25 1989-07-25 Sandoz Pharm. Corp. Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
US4927851A (en) * 1986-01-07 1990-05-22 Sandoz Pharm. Corp. Analogs of mevalonolactone and derivatives thereof
US4829081A (en) * 1986-01-07 1989-05-09 Sandoz Pharm. Corp. Analogs of mevalonolactone and derivatives thereof
US4751235A (en) * 1986-12-23 1988-06-14 Sandoz Pharm. Corp. Anti-atherosclerotic indolizine derivatives
US4939159A (en) * 1986-09-10 1990-07-03 Sandoz Pharm. Corp. Azaindole derivatives useful as cholesterol biosynthesis inhibitors
JP2569746B2 (en) * 1987-08-20 1997-01-08 日産化学工業株式会社 Quinoline mevalonolactones
EP0308736A3 (en) * 1987-09-12 1990-02-14 Nissan Chemical Industries Ltd. Pyrimidine type mevalonolactones
US4868185A (en) * 1987-12-10 1989-09-19 Warner-Lambert Company 6-[[Substituted)pyrimidinyl)ethyl]- and ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4822799A (en) * 1988-01-27 1989-04-18 Sandoz Pharm. Corp. Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals
ES2019163A6 (en) * 1988-10-03 1991-06-01 Glaxo Group Ltd Imidazole derivatives and their use as hypercholesterolemia and hyperlipoproteinemia agents
FI94339C (en) * 1989-07-21 1995-08-25 Warner Lambert Co Process for the preparation of pharmaceutically acceptable [R- (R *, R *)] - 2- (4-fluorophenyl) -, - dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl] -1H- for the preparation of pyrrole-1-heptanoic acid and its pharmaceutically acceptable salts
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5177080A (en) * 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
JP2648897B2 (en) * 1991-07-01 1997-09-03 塩野義製薬株式会社 Pyrimidine derivatives
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
PT1099694E (en) * 1998-07-23 2005-10-31 Nissan Chemical Ind Ltd PROCESS FOR THE PREPARATION OF A QUINOLINE DERIVATIVE AND AN INTERMEDIARY FOR THAT END
GB0001662D0 (en) * 1999-02-06 2000-03-15 Zeneca Ltd Pharmaceutical compositions
JP2002538202A (en) * 1999-03-08 2002-11-12 メルク エンド カムパニー インコーポレーテッド Dihydroxy open acid of HMG-CoA reductase inhibitor and salt thereof
WO2001054694A1 (en) * 2000-01-28 2001-08-02 Bristol-Myers Squibb Company Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
US8186012B2 (en) * 2004-06-03 2012-05-29 The Wooster Brush Company Pole grip with storage compartment

Similar Documents

Publication Publication Date Title
AU2001241095A1 (en) Preventives and/or remedies for hyperphosphatemia
EP1157707B8 (en) Method and composition for deforming soft tissues
AU2001241168A1 (en) Drugs for complications of diabetes and neuropathy and utilization thereof
AU2002324737A1 (en) Anti-cancer and wound healing compounds
AU2635201A (en) Direct manipulation of displayed content
AU2001267079A1 (en) Integrated electronic-optoelectronic devices and method of making the same
AU2002354056A1 (en) Remedies for urinary frequency
AU2337799A (en) Method and compositions for promotion of wound healing
AUPQ246799A0 (en) Surgical screw and guidewire
AU2000276362A1 (en) Composition for the treatment of diabetes
AU7907300A (en) Novel combination of loteprednol and antihistamines
AU5111800A (en) Method of operating freight market over the internet
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
AU2002346622A1 (en) Electrosphincterotome and manometry catheter
AU2002231206A1 (en) Treatment of depression
AU2001294221A1 (en) Preventives and remedies for complications of diabetes
WO2001091700A8 (en) Composition and method for enhancing elasticity of tissue
HUP0303353A3 (en) Preventives and remedies for complications of diabetes
AU2002224596A1 (en) Preventives or remedies for obesity or fatty liver
AU2001232271A1 (en) Preventives/remedies for postoperative stress
AU2001258836A1 (en) Preventives and remedies for pulmonary hypertension
AU2002235153A1 (en) Medical guidewire and method for making
AU2001241162A1 (en) Remedies for allergic diseases
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor